Impact of public health insurance coverage of novel anticancer medication on medical expenditure and patient affordability in a provincial medical centre of China: a propensity score-matching analysis with the quasi-experimental design

INTRODUCTION: Little is known about the impact of the government’s efforts in having novel anticancer medicines covered by the public health insurance system in China. This study targeted the above policy implemented in Fujian province in 2017, analysed the policy impact on the medical expenditure o...

Descripción completa

Detalles Bibliográficos
Autores principales: Diao, Yifan, Lin, Mengbo, Xu, Kai, Huang, Ji, Wu, Xiongwei, Li, Mingshuang, Sun, Jing, Li, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852767/
https://www.ncbi.nlm.nih.gov/pubmed/35173004
http://dx.doi.org/10.1136/bmjopen-2021-054713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852767/
https://www.ncbi.nlm.nih.gov/pubmed/35173004
http://dx.doi.org/10.1136/bmjopen-2021-054713

Ejemplares similares